Literature DB >> 26857774

Lung Transplantation for Cystic Fibrosis.

Matthew R Morrell1, Joseph M Pilewski2.   

Abstract

Lung transplantation is a viable option for many patients with cystic fibrosis (CF) and end-stage lung disease. Criteria for transplant in patients with CF vary widely among transplant centers in terms of acceptable comorbidities; referral to multiple centers may be necessary to maximize patient opportunity for this potentially life-prolonging intervention. Early referral is critical to patient education and modification of risk factors associated with worse outcomes. If transplant evaluation has been completed, patients with CF and respiratory failure requiring mechanical ventilation and extracorporeal membrane oxygenation may remain viable candidates for transplant with outcomes comparable to other individuals with CF.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced lung disease; Burkholderia cepacia; Cystic fibrosis; Lung transplantation; Nontuberculous mycobacteria; Respiratory failure

Mesh:

Year:  2016        PMID: 26857774     DOI: 10.1016/j.ccm.2015.11.008

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  11 in total

Review 1.  Cystic fibrosis: a clinical view.

Authors:  Carlo Castellani; Baroukh M Assael
Journal:  Cell Mol Life Sci       Date:  2016-10-05       Impact factor: 9.261

2.  Low body mass index as a barrier to lung transplant in cystic fibrosis.

Authors:  Ann L Jennerich; Joseph B Pryor; Travis Y Hee Wai; Siddhartha G Kapnadak; Moira L Aitken; Christopher H Goss; Kathleen J Ramos
Journal:  J Cyst Fibros       Date:  2021-12-23       Impact factor: 5.527

3.  High-Dose Inhaled Nitric Oxide as Adjunct Therapy in Cystic Fibrosis Targeting Burkholderia multivorans.

Authors:  Bethany L Bartley; Kelly J Gardner; Stefano Spina; Bryan P Hurley; David Campeau; Lorenzo Berra; Lael M Yonker; Ryan W Carroll
Journal:  Case Rep Pediatr       Date:  2020-06-24

4.  Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation: A United Network for Organ Sharing Registry Study.

Authors:  Kathleen J Ramos; Siddhartha G Kapnadak; Miranda C Bradford; Ranjani Somayaji; Eric D Morrell; Joseph M Pilewski; Erika D Lease; Michael S Mulligan; Moira L Aitken; Cynthia J Gries; Christopher H Goss
Journal:  Chest       Date:  2020-01-17       Impact factor: 9.410

Review 5.  Review of Rapid Advances in Cystic Fibrosis.

Authors:  Stephanie L Link; Ravi P Nayak
Journal:  Mo Med       Date:  2020 Nov-Dec

6.  Body Mass Index Recovery after Lung Transplant for Cystic Fibrosis.

Authors:  Joseph B Pryor; Miranda C Bradford; Ann L Jennerich; Travis Y Hee Wai; Joseph M Pilewski; Siddhartha G Kapnadak; Moira L Aitken; Christopher H Goss; Kathleen J Ramos
Journal:  Ann Am Thorac Soc       Date:  2022-07

7.  Outcomes of Children With Cystic Fibrosis Admitted to PICUs.

Authors:  Michael A Smith; Meghan E McGarry; Ngoc P Ly; Matt S Zinter
Journal:  Pediatr Crit Care Med       Date:  2020-10       Impact factor: 3.971

8.  Novel antibiotic combinations proposed for treatment of Burkholderia cepacia complex infections.

Authors:  Omar M El-Halfawy; Marwa M Naguib; Miguel A Valvano
Journal:  Antimicrob Resist Infect Control       Date:  2017-11-25       Impact factor: 4.887

Review 9.  Modular Approach to Select Bacteriophages Targeting Pseudomonas aeruginosa for Their Application to Children Suffering With Cystic Fibrosis.

Authors:  Victor Krylov; Olga Shaburova; Elena Pleteneva; Maria Bourkaltseva; Sergey Krylov; Alla Kaplan; Elena Chesnokova; Leonid Kulakov; Damian Magill; Olga Polygach
Journal:  Front Microbiol       Date:  2016-10-13       Impact factor: 5.640

10.  Lung transplant referral practice patterns: a survey of cystic fibrosis physicians and general pulmonologists.

Authors:  Bethany L Bartley; Carolyn E Schwartz; Roland B Stark; Anna M Georgiopoulos; Deborah Friedman; Christopher J Richards; Henry L Dorkin; T Bernard Kinane; Isabel P Neuringer; Lael M Yonker
Journal:  BMC Pulm Med       Date:  2020-03-04       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.